[1]
Obaidurrahman Md Haroon, “CLASSIFYING NEW ANTI-TUBERCULOSIS DRUGS AND MANAGEMENT OF ITS ADR AS PER WHO: A SHORT REVIEW”, World J Pharm Sci, vol. 12, no. 02, Jul. 2024.